A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer.
Saved in:
| Title: | A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer. |
|---|---|
| Authors: | Chao Y; Department of Oncology Medicine, Taipei Veterans General Hospital, Taipei, Taiwan., Hsieh JS, Yeh HT, Su YC, Wu CC, Chen JS, Tai CJ, Bai LY, Yeh KH, Su WC, Li CP |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2014 Apr; Vol. 73 (4), pp. 799-806. Date of Electronic Publication: 2014 Feb 17. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
